Prognosis

"Prognosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.

Descriptor ID	D011379
MeSH Number(s)	E01.789
Concept/Terms	Prognosis Prognosis Prognoses Prognostic Factors Prognostic Factors Factor, Prognostic Factors, Prognostic Prognostic Factor

Below are MeSH descriptors whose meaning is more general than "Prognosis".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Diagnosis [E01]
Prognosis [E01.789]

Below are MeSH descriptors whose meaning is related to "Prognosis".

Below are MeSH descriptors whose meaning is more specific than "Prognosis".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Prognosis" by people in this website by year, and whether "Prognosis" was a major or minor topic of these publications.

Bar chart showing 1209 publications over 31 distinct years, with a maximum of 86 publications in 2018

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	0	4	4
1996	0	7	7
1997	0	7	7
1998	0	7	7
1999	0	9	9
2000	0	9	9
2001	0	10	10
2002	0	24	24
2003	0	28	28
2004	0	29	29
2005	0	36	36
2006	0	37	37
2007	0	39	39
2008	0	48	48
2009	0	56	56
2010	0	45	45
2011	0	53	53
2012	0	55	55
2013	1	72	73
2014	1	70	71
2015	1	71	72
2016	1	60	61
2017	0	53	53
2018	1	85	86
2019	0	72	72
2020	1	80	81
2021	0	42	42
2022	0	21	21
2023	0	24	24
2024	0	33	33
2025	0	17	17

Below are the most recent publications written about "Prognosis" by people in Profiles.

Gregory WM, Prior TJ, Bartlett JB, Sonneveld P, Dimopoulos MA, Moreau P, Usmani S, Facon T. Modeling MRD Changes in Myeloma to Understand Treatment Effects, Predict Outcomes, and Investigate Curative Potential. Clin Cancer Res. 2025 Jun 03; 31(11):2154-2161.

View in: PubMed
Roy R, Schunkert EM, Olivova P, Gilar M, Geromanos S, Li GZ, Gebler J, Dagher A, El-Hayek A, Aldakhlallah R, Staffa SJ, Zurakowski D, Lotz M, Pories S, Moses MA. Identification of vitronectin as a potential non-invasive biomarker of metastatic breast cancer using a label-free LC-MS/MS approach. Breast Cancer Res. 2025 May 29; 27(1):94.

View in: PubMed
Freitas AJA, Causin RL, Calfa S, Santana IVV, Balie M, Hirai W, Laus AC, Araujo HS, Hidalgo Filho CM, de Oliveira Bombarda F, da Silva VD, Evangelista AF, de P?dua Souza C, Reis RM, Marques MMC. Exploring the Nottingham classification: assessing gene expression profiles in breast cancer patients and their association with outcomes. Breast Cancer Res Treat. 2025 Jul; 212(2):237-250.

View in: PubMed
Sorroche BP, de Jesus Teixeira R, de Souza VG, Tosi IC, Tostes K, Laus AC, Santana IVV, de Lima Vazquez V, Arantes LMRB. CD24, NFIL3, FN1, and KLRK1 signature predicts melanoma immunotherapy response and survival. J Mol Med (Berl). 2025 Jun; 103(6):725-737.

View in: PubMed
You B, Anderson C, Cecere SC, Carrot A, Myers T, Heitz F, Sharma S, Sel?ukbiricik F, Aghajanian C, Fernebro J, Blank S, Laudani ME, Thaker PH, Yunokawa M, Willmott L, Lisyanskaya A, Hegg R, He Y, Landen C, Lin YG, Alarc?n J, Moore KN. Impact of adding the immune checkpoint inhibitor atezolizumab to first-line chemotherapy on progression-free survival in poor-prognosis ovarian cancer: A retrospective analysis from the IMagyn050 trial. Gynecol Oncol. 2025 Jun; 197:66-73.

View in: PubMed
Huang Z, Li Y, Bucci V, Haran JP. Decoding cancer prognosis with deep learning: the ASD-cancer framework for tumor microenvironment analysis. mSystems. 2025 May 20; 10(5):e0145524.

View in: PubMed
Khouri MR, Wang B, Pearson LK, Gillis-Smith AJ, Suzuki S, Hutchinson LM, Bindal P, Ramanathan M, Gerber JM, Cerny J, Patel SA. Characteristics and clinical outcomes of patients with myeloid malignancies and cohesin mutations. Cancer. 2025 Apr 15; 131(8):e35846.

View in: PubMed
Biran N, Dhakal B, Niesvizky R, Lentzsch S, Bhutani D, McKay JT, Vesole DH, Nooka A, Paul B, Hari PN, D'Ambrosi S, Kuiper R, van Vliet M, Siegel D, Usmani SZ, van Rhee F. Enhancing risk stratification and treatment decision in multiple myeloma with SKY92 gene expression profiling in real-world data. Br J Haematol. 2025 Jun; 206(6):1642-1653.

View in: PubMed
Eche-Ugwu IJ, Mazzola E, Stevens SE, Wolfe J, Feraco AM. Illness Uncertainty in Parents of Children With Cancer-An Exploratory Analysis to Inform Intervention Development. Pediatr Blood Cancer. 2025 Jul; 72(7):e31726.

View in: PubMed
Nourmohammadi M, Rahimi Moghadam S, Jalalian Moghadam A, Yari S. Assessment of Cancer Rate in Mine Workers Exposed to Crystalline Silica. Asian Pac J Cancer Prev. 2025 Apr 01; 26(4):1173-1179.

View in: PubMed

People

Explore

Similar Concepts

Top Journals